Bruker Co. (NASDAQ:BRKR) Shares Purchased by CIBC Asset Management Inc

CIBC Asset Management Inc increased its holdings in shares of Bruker Co. (NASDAQ:BRKR) by 5.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 4,233 shares of the medical research company’s stock after acquiring an additional 223 shares during the period. CIBC Asset Management Inc’s holdings in Bruker were worth $248,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of BRKR. Retirement Systems of Alabama boosted its holdings in Bruker by 11.7% in the 3rd quarter. Retirement Systems of Alabama now owns 134,254 shares of the medical research company’s stock worth $9,272,000 after buying an additional 14,069 shares during the last quarter. Cerity Partners LLC boosted its holdings in Bruker by 446.8% in the 3rd quarter. Cerity Partners LLC now owns 27,998 shares of the medical research company’s stock worth $1,934,000 after buying an additional 22,878 shares during the last quarter. Merit Financial Group LLC acquired a new stake in Bruker in the 4th quarter worth about $300,000. Brown Brothers Harriman & Co. boosted its holdings in Bruker by 39.9% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 602,144 shares of the medical research company’s stock worth $41,584,000 after buying an additional 171,806 shares during the last quarter. Finally, FMR LLC boosted its holdings in Bruker by 21.4% in the 3rd quarter. FMR LLC now owns 14,306,122 shares of the medical research company’s stock worth $987,981,000 after buying an additional 2,521,904 shares during the last quarter. 79.52% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the company. UBS Group assumed coverage on Bruker in a report on Tuesday, December 10th. They issued a “neutral” rating and a $66.00 price objective on the stock. The Goldman Sachs Group upgraded Bruker from a “sell” rating to a “neutral” rating and set a $60.00 price objective on the stock in a report on Thursday, December 5th. Bank of America boosted their target price on Bruker from $78.00 to $80.00 and gave the stock a “buy” rating in a report on Friday, December 13th. Barclays lowered their target price on Bruker from $69.00 to $65.00 and set an “overweight” rating on the stock in a report on Monday, February 10th. Finally, Citigroup lowered their target price on Bruker from $80.00 to $75.00 and set a “buy” rating on the stock in a report on Wednesday, November 6th. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, Bruker currently has a consensus rating of “Moderate Buy” and a consensus target price of $70.50.

Bruker Stock Down 1.7 %

BRKR stock opened at $50.99 on Wednesday. The firm has a market cap of $7.73 billion, a PE ratio of 67.09, a PEG ratio of 2.16 and a beta of 1.16. The company has a debt-to-equity ratio of 1.15, a quick ratio of 0.77 and a current ratio of 1.60. The firm’s 50 day moving average price is $56.49 and its 200-day moving average price is $59.87. Bruker Co. has a one year low of $48.07 and a one year high of $94.86.

Bruker (NASDAQ:BRKR) last released its quarterly earnings results on Thursday, February 13th. The medical research company reported $0.76 EPS for the quarter, beating the consensus estimate of $0.75 by $0.01. Bruker had a net margin of 3.36% and a return on equity of 21.01%. On average, equities research analysts anticipate that Bruker Co. will post 2.69 EPS for the current year.

Bruker Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, March 28th. Shareholders of record on Monday, March 17th will be given a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a yield of 0.39%. The ex-dividend date of this dividend is Monday, March 17th. Bruker’s payout ratio is 26.32%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.